Analysts’ Viewpoint on Cat Allergy in Humans Market Scenario
Rising popularity of cats as pets is triggering pet allergic responses in their owners. For instance, cat allergy is highly common in the U.S. and Europe; skin prick tests reveal that 17% of the U.S. population and 8% of the EU population are allergic to cats. Moreover, some families seem to be more susceptible to allergy reactions than others. Therefore, children born into these families are more likely to have allergic diseases. Atopic dermatitis is thought to be linked to this hereditary tendency to develop such diseases. The diagnosis and treatment of patients with allergies pose a challenge. It has been assumed that continuous exposure to cat allergens leads to allergic sensitization and progression to clinically relevant allergic symptoms. Allergy to dogs and cats has long been considered a major risk factor in the development of allergic rhinitis and asthma.
When people are exposed to various pets, such as dogs and cats, they develop a variety of allergies. The most common types of allergies are runny nose, sneezing, nasal congestion, itchy eyes, as well as skin rash. Allergies to cat is a human allergic reaction to allergens produced by cats. Cat allergens of the most common types are Fel d1 (secreted by the cat's sebaceous glands) and Fel d4 (found in the cat's saliva). pet allergy affects nearly 25% of allergic patients due to Fel d1 and Fel d4 proteins. Cat allergens, particularly Fel d1, are abundant in the form of dander and are thought to be a major cause of allergic asthma around the world. The primary treatment for allergic patients is to avoid cats. Certain allergy Treatment and allergy shots, on the other hand, can help control the symptoms of cat allergies.
Pet humanization is becoming a globally accepted term in the pet industry, as an increasing number of pet owners want to provide their pets with human-like products or experiences. For instance, according to Pet data, in 2018, the adoption rate for dogs in China was 11.8% and 19.9% for cats. Increase in R&D for drugs and vaccines for treatment or prevention of pet allergy is expected to drive the demand across the globe.
According to data from Allergy, Asthma & Immunology Research, in 2018, allergies to dogs and cats affected 10% to 20% of the global population with allergic rhino conjunctivitis and allergic asthma. Rising prevalence of various types of pet allergies, increasing investment by manufacturers in the development of novel Cat allergy therapeutics, and growing importance of self-medication are primary factors driving the market.
An article published by Allergy U.K. stated that children born into families with a history of allergies are more likely to develop allergies as compared to other children. Increase in tendency of families and children to develop allergies due to their genetic links is known as ‘being atopic’. Researchers have estimated that half of the children from atopic families are likely to have allergies themselves. However, this rate in children from non-atopic families is 1 in 5 children who may go on to have an allergy.
Along with lifestyle changes, changing climate with increased pollution, CO2 levels, and particulate matter (PM) across the world are pushing the prevalence and intensity of allergies. In 2020, according to the World Allergy Organization (WAO), allergic rhinitis was one of the most prevalent allergies, affecting 400 million people globally.
In terms of treatment, the antihistamines segment is projected to dominate the market and account for 50% share by 2031. Antihistamines are the first line of treatment in case of pet allergies. They are cost-effective, easily available, and provide immediate relief. Antihistamines treat allergy symptoms such as nasal congestion, runny nose, sneezing, or itching, nasal passage enlargement, hives, and other skin rashes, and itchy, runny eyes. Treating these symptoms can help the patient feel better during the day and sleep better at night. The antihistamine dosage is determined by the allergy symptoms.
Based on application, the allergy treatment segment accounted for a major share of 95% of the global market in 2021. Easy availability and low cost of anti-allergy drugs are expected to drive the segment during the forecast period. The growth of the segment is due to rise in prevalence of allergic rhinitis and the expansion of government-funded healthcare programmes to raise awareness about cat litter allergy in humans. Increasing pollution levels around the world as well as distinct genetic changes are driving the allergy treatment segment. Moreover, increase in adoption of immunotherapy to treat pet allergy conditions, owing to good efficacy of therapy is expected to propel the segment over the next few years.
North America dominated the global cat allergy in humans market in 2021. The market in the region is anticipated to grow at a CAGR of 6.1% from 2022 to 2031. The growth of the market in North America can be attributed to high prevalence of cat allergy in humans and increase in pet cat population.
According to the American Academy of Allergy, Asthma, and Immunology, Pet allergies (cat) affect about 15% of the U.S. population each year. In 2014, it was also reported that approximately 14% of children aged 6 to 19 were allergic to cats.
The market in Asia Pacific is estimated to grow at a notable CAGR rate during the forecast period, due to development of appropriate healthcare infrastructure and rise in awareness about progressive immunotherapy, such as allergen immunotherapy, in allergy treatment. Increase in awareness about pet Allergy is also fueling the market in Asia Pacific.
The cat allergy in humans market report concludes with the company profiles section, which includes information about key players in the global cat allergy in humans market. Leading players analyzed in the report include Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma, Cipla Limited, GlaxoSmithKline plc, Merck & Co., Inc, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Sanofi, and Stallergenes Greer.
Each of these players has been profiled in the cat allergy in humans market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 4.1 Bn |
|
Market Forecast Value in 2031 |
US$ 7.8 Bn |
|
Growth Rate |
CAGR of 6.3 % from Year-to-Year |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global cat allergy in humans market was valued over US$ 4.2 Bn in 2021
The global cat allergy market is projected to surpass US$ 7.8 Bn by 2031
The global cat allergy in humans market is anticipated to record a CAGR of 6.3% from 2022 to 2031
Increase in adoption of cats as pets and rise in prevalence of pet allergy have a positive impact on the global market
The antihistamines treatment segment held over 50% share of the global cat allergy in humans market in 2021
North America is expected to account for a major share of the global market during the forecast period
Prominent players in the global cat allergy in humans market include Bayer AG, Covis Pharma B.V, HollisterStier Allergy (Jubilant Pharma, Cipla Limited, GlaxoSmithKline plc, Merck & Co., Inc, Regeneron Pharmaceuticals, Inc, Saiba Animal Health AG, Sanofi, and Stallergenes Greer
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cat Allergy in Humans Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cat Allergy in Humans Market Analysis and Forecasts, 2017–2031
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Allergy Prevalence Data
5.3. Pipeline Analysis
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Cat Allergy in Humans Market Analysis and Forecasts, By Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Treatment, 2017–2031
6.3.1.1. Antihistamines
6.3.2. Corticosteroid Nasal Sprays
6.3.3. Decongestants
6.3.4. Leukotriene Inhibitors
6.3.5. Others
6.4. Market Attractiveness By Treatment
7. Global Cat Allergy in Humans Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017–2031
7.3.1. Allergy Treatment
7.3.2. Allergy Prevention
7.4. Market Attractiveness By Application
8. Global Cat Allergy in Humans Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Distribution Channel, 2017–2031
8.3.1. Hospital pharmacies
8.3.2. Retail pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness By Distribution Channel
9. Global Cat Allergy in Humans Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Cat Allergy in Humans Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Treatment, 2017–2031
10.2.1. Antihistamines
10.2.2. Corticosteroid Nasal Sprays
10.2.3. Decongestants
10.2.4. Leukotriene Inhibitors
10.2.5. Others
10.3. Market Value Forecast By Application, 2017–2031
10.3.1. Allergy Treatment
10.3.2. Allergy Prevention
10.4. Market Value Forecast By Distribution Channel, 2017–2031
10.4.1. Hospital pharmacies
10.4.2. Retail pharmacies
10.4.3. Online Pharmacies
10.5. Market Value Forecast By Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Treatment
10.6.2. By Application
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Cat Allergy in Humans Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Treatment, 2017–2031
11.2.1. Antihistamines
11.2.2. Corticosteroid Nasal Sprays
11.2.3. Decongestants
11.2.4. Leukotriene Inhibitors
11.2.5. Others
11.3. Market Value Forecast By Application, 2017–2031
11.3.1. Allergy Treatment
11.3.2. Allergy Prevention
11.4. Market Value Forecast By Distribution Channel, 2017–2031
11.4.1. Hospital pharmacies
11.4.2. Retail pharmacies
11.4.3. Online Pharmacies
11.5. Market Value Forecast By Country, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Treatment
11.6.2. By Application
11.6.3. By Distribution Channel
11.6.4. By Country
12. Asia Pacific Cat Allergy in Humans Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Treatment, 2017–2031
12.2.1. Antihistamines
12.2.2. Corticosteroid Nasal Sprays
12.2.3. Decongestants
12.2.4. Leukotriene Inhibitors
12.2.5. Others
12.3. Market Value Forecast By Application, 2017–2031
12.3.1. Allergy Treatment
12.3.2. Allergy Prevention
12.4. Market Value Forecast By Distribution Channel, 2017–2031
12.4.1. Hospital pharmacies
12.4.2. Retail pharmacies
12.4.3. Online Pharmacies
12.5. Market Value Forecast By Country, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Treatment
12.6.2. By Application
12.6.3. By Distribution Channel
12.6.4. By Country
13. Latin America Cat Allergy in Humans Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Treatment, 2017–2031
13.2.1. Antihistamines
13.2.2. Corticosteroid Nasal Sprays
13.2.3. Decongestants
13.2.4. Leukotriene Inhibitors
13.2.5. Others
13.3. Market Value Forecast By Application, 2017–2031
13.3.1. Allergy Treatment
13.3.2. Allergy Prevention
13.4. Market Value Forecast By Distribution Channel, 2017–2031
13.4.1. Hospital pharmacies
13.4.2. Retail pharmacies
13.4.3. Online Pharmacies
13.5. Market Value Forecast By Country, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Treatment
13.6.2. By Application
13.6.3. By Distribution Channel
13.6.4. By Country
14. Middle East & Africa Cat Allergy in Humans Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Treatment, 2017–2031
14.2.1. Antihistamines
14.2.2. Corticosteroid Nasal Sprays
14.2.3. Decongestants
14.2.4. Leukotriene Inhibitors
14.2.5. Others
14.3. Market Value Forecast By Application, 2017–2031
14.3.1. Allergy Treatment
14.3.2. Allergy Prevention
14.4. Market Value Forecast By Distribution Channel, 2017–2031
14.4.1. Hospital pharmacies
14.4.2. Retail pharmacies
14.4.3. Online Pharmacies
14.5. Market Value Forecast By Country, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Treatment
14.6.2. By Application
14.6.3. By Distribution Channel
14.6.4. By Country
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Covis Pharma B.V
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. HollisterStier Allergy.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. GlaxoSmithKline plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Merck & Co. Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Regeneron Pharmaceuticals, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Saiba Animal Health AG
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Sanofi, Stallergenes Greer
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
List of Tables
Table 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 02: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 03: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 05: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 08: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 09: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 11: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 12: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 13: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 14: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 16: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 18: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 19: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia-Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 21: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 23: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 24: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 26: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Treatment, 2017‒2031
Table 28: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Antihistamines, 2017‒2031
Table 29: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
List of Figures
Figure 01: Global Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Cat Allergy in Humans Market Value Share, by Treatment, 2020
Figure 03: Cat Allergy in Humans Market Value Share, by Application, 2020
Figure 04: Cat Allergy in Humans Market Value Share, by Distribution Channel, 2020
Figure 05: Global Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 06: Global Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 07: Global Cat Allergy in Humans Market Value (US$ Mn), by Antihistamines, 2017‒2031
Figure 08: Global Cat Allergy in Humans Market Value (US$ Mn), by Corticosteroid Nasal Sprays, 2017‒2031
Figure 09: Global Cat Allergy in Humans Market Value (US$ Mn), by Decongestants, 2017‒2031
Figure 10: Global Cat Allergy in Humans Market Value (US$ Mn), by Leukotriene Inhibitors, 2017‒2031
Figure 11: Global Cat Allergy in Humans Market Value (US$ Mn), by Others, 2017‒2031
Figure 12: Global Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
Figure 13: Global Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031
Figure 14: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Allergy Treatment, 2017–2031
Figure 15: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Allergy Prevention, 2017–2031
Figure 16: Global Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 17: Global Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 18: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Hospital Pharmacies, 2017–2031
Figure 19: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Retail Pharmacies, 2017–2031
Figure 20: Global Cat Allergy in Humans Market Revenue (US$ Mn), by Online Pharmacies, 2017–2031
Figure 21: Global Cat Allergy in Humans Market Value Share Analysis, by Region, 2020 and 2031
Figure 22: Global Cat Allergy in Humans Market Attractiveness Analysis, by Region, 2021–2031
Figure 23: North America Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031
Figure 24: North America Cat Allergy in Humans Market Value Share Analysis, by Country, 2020 and 2031
Figure 25: North America Cat Allergy in Humans Market Attractiveness Analysis, by Country, 2021–2031
Figure 26: North America Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 27: North America Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 28: North America Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
Figure 29: North America Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031
Figure 30: North America Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 31: North America Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 32: Europe Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031
Figure 33: Europe Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 34: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 35: Europe Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 36: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 37: Europe Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
Figure 38: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031
Figure 39: Europe Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 40: Europe Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 41: Asia Pacific Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031
Figure 42: Asia Pacific Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 43: Asia Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 44: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Treatment, 2020 and 2031
Figure 45: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 46: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
Figure 47: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031
Figure 48: Asia-Pacific Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 49: Asia-Pacific Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 50: Latin America Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031
Figure 51: Latin America Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 52: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 53: Latin America Cat Allergy in Humans Market Value Share Analysis, by Treatment , 2020 and 2031
Figure 54: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 55: Latin America Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
Figure 56: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031
Figure 57: Latin America Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 58: Latin America Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Figure 59: Middle East & Africa Cat Allergy in Humans Market Value (US$ Mn) Forecast, 2017–2031
Figure 60: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 61: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 62: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Treatment , 2020 and 2031
Figure 63: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Treatment, 2021–2031
Figure 64: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Application, 2020 and 2031
Figure 65: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Application, 2021–2031
Figure 66: Middle East & Africa Cat Allergy in Humans Market Value Share Analysis, by Distribution Channel, 2020 and 2031
Figure 67: Middle East & Africa Cat Allergy in Humans Market Attractiveness Analysis, by Distribution Channel, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cat Allergy in Humans Market
